MS/MS to Targeted Proteomics (MRM)

Similar documents
Lecture 3. Tandem MS & Protein Sequencing

Introduction to Proteomics 1.0

Mass Spectrometry. Mass spectrometer MALDI-TOF ESI/MS/MS. Basic components. Ionization source Mass analyzer Detector

Proteomics/Peptidomics

New Instruments and Services

Considerations of the use of Triple Quadrupoles or Ion Traps in Quantitative Applications

Ion Source. Mass Analyzer. Detector. intensity. mass/charge

Proteins: Proteomics & Protein-Protein Interactions Part I

Comparison of mass spectrometers performances

1. Sample Introduction to MS Systems:

Shotgun Proteomics MS/MS. Protein Mixture. proteolysis. Peptide Mixture. Time. Abundance. Abundance. m/z. Abundance. m/z 2. Abundance.

SCS Mass Spectrometry Laboratory

Mass Spectrometry. - Introduction - Ion sources & sample introduction - Mass analyzers - Basics of biomolecule MS - Applications

4th Multidimensional Chromatography Workshop Toronto (January, 2013) Herman C. Lam, Ph.D. Calibration & Validation Group

New Instruments and Services

Application Note # LCMS-89 High quantification efficiency in plasma targeted proteomics with a full-capability discovery Q-TOF platform

2. Ionization Sources 3. Mass Analyzers 4. Tandem Mass Spectrometry

Biological Mass spectrometry in Protein Chemistry

Mass Spectrometry Course Árpád Somogyi Chemistry and Biochemistry MassSpectrometry Facility) University of Debrecen, April 12-23, 2010

LC/MS/MS SOLUTIONS FOR LIPIDOMICS. Biomarker and Omics Solutions FOR DISCOVERY AND TARGETED LIPIDOMICS

MASS SPECTROMETRY IN METABOLOMICS

Quantification with Proteome Discoverer. Bernard Delanghe

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT

REDOX PROTEOMICS. Roman Zubarev.

Learning Objectives. Overview of topics to be discussed 10/25/2013 HIGH RESOLUTION MASS SPECTROMETRY (HRMS) IN DISCOVERY PROTEOMICS

MALDI-TOF. Introduction. Schematic and Theory of MALDI

An Alternative Approach: Top-Down Bioanalysis of Intact Large Molecules Can this be part of the future? Lecture 8, Page 27

Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS

Using Software Tools to Improve the Detection of Impurities by LC/MS. Application Note. Christine Miller Agilent Technologies.

Fundamentals of Soft Ionization and MS Instrumentation

Improving Selectivity in Quantitative Analysis Using MS 3 on a Hybrid Quadrupole-Linear Ion Trap Mass Spectrometer

Ultra Performance Liquid Chromatography Coupled to Orthogonal Quadrupole TOF MS(MS) for Metabolite Identification

Designer Cannabinoids

RDP Cores Highlights: the CF Analytics Core. Facundo M. Fernández School of Chemistry and Biochemistry Georgia Institute of Technology

PTM Discovery Method for Automated Identification and Sequencing of Phosphopeptides Using the Q TRAP LC/MS/MS System

The 1997 ABRF Mass Spectrometry Committee Collaborative Study: Identification of Phosphopeptides in a Tryptic Digest of Apomyoglobin

How to Use TOF and Q-TOF Mass Spectrometers

Mass spectra of peptides and proteins - and LC analysis of proteomes Stephen Barnes, PhD

Relative Quantitation of Human Polymorphonuclear Leukocyte Cell Membrane GPEtn Lipids

Quantification by Mass Spectrometry

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Research to Routine Workflows for Large and Small Molecules using the Q Exactive HR/MS

for the Identification of Phosphorylated Peptides

MS1 and MS2 crosstalk in label free quantitation of mass spectrometry data independent acquisitions

More structural information with MS n

Metabolomics: quantifying the phenotype

Mass Spectrometry Infrastructure

Mass Spectrometry and Proteomics. Professor Xudong Yao Bioanalytical Chemistry Spring 2007

Types of Modifications

The Comparison of High Resolution MS with Triple Quadrupole MS for the Analysis of Oligonucleotides

NIH Public Access Author Manuscript J Proteome Res. Author manuscript; available in PMC 2014 July 05.

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

* Skyline LC SRM. 2 Skyline LC-MS/MS. Skyline University of Washington Windows.

New Developments in LC-IMS-MS Proteomic Measurements and Informatic Analyses

Achieve Broad Lipid Quantitation using a High-Throughput Targeted Lipidomics Method

Automated Purification and Analytical Reinjection of a Small Molecule Drug, Probenecid, on a Gilson LC/MS Dual Function System

Phosphorylation of proteins Steve Barnes Feb 19th, 2002 in some cases, proteins are found in a stable, hyperphosphorylated state, e.g.

Supplementary Figures and Notes for Digestion and depletion of abundant

Methods in Mass Spectrometry. Dr. Noam Tal Laboratory of Mass Spectrometry School of Chemistry, Tel Aviv University

The use of mass spectrometry in lipidomics. Outlines

MASS SPECTROMETRY BASED METABOLOMICS. Pavel Aronov. ABRF2010 Metabolomics Research Group March 21, 2010

SEPARATION OF BRANCHED PFOS ISOMERS BY UPLC WITH MS/MS DETECTION

Impurity Identification using a Quadrupole - Time of Flight Mass Spectrometer QTOF

Target Analyses in Parallel Reaction Monitoring Mode (PRM)

Quantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 6410 Triple Quadrupole LC/MS system

MALDI Imaging Drug Imaging Detlev Suckau Head of R&D MALDI Bruker Daltonik GmbH. December 19,

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Towards High Resolution MS in Regulated Bioanalysis

New Mass Spectrometry Tools to Transform Metabolomics and Lipidomics

Summary Chapter 8 CHAPTER 8. Summary. Page 173

Topics. Protein Bioinformatics ( ) How a Mass Spectrometers Measure Mass. Lecture 9: Quantitative Proteomics Tuesday, April 27, 2010

Chip-Based E-Tip SPE followed by Infusion MS. Copyright by Jack Henion, 2015 Lecture 1, Page 30

Nature Biotechnology: doi: /nbt Supplementary Figure 1

Protein Reports CPTAC Common Data Analysis Pipeline (CDAP)

Determination of N-Nitrososarcosine (NSAR) in tobacco

Supporting Information

Fast, Robust and Reliable Method for the Identification and Quantitation of Sildenafil Residue in Honey using LC-MS/MS

amazon Turning Speed into Solutions

Technical Note # TN-31 Redefining MALDI-TOF/TOF Performance

Profiling the Distribution of N-Glycosylation in Therapeutic Antibodies using the QTRAP 6500 System

SWATH Acquisition Enables the Ultra-Fast and Accurate Determination of Novel Synthetic Opioids

Measuring Lipid Composition LC-MS/MS

Quadrupole and Ion Trap Mass Analysers and an introduction to Resolution

Unbiased in-depth characterization of CEX fractions from a stressed mab by MS. Matthias Berg, Novartis Pharma, BTDM

US-HUPO 2011 Agilent lunch seminar. Robert Moritz. Developing a Complete and Reproducible Human SRMAtlas. Duchy of Luxembourg.

Proteomic Biomarker Discovery in Breast Cancer

Don t miss a thing on your peptide mapping journey How to get full coverage peptide maps using high resolution accurate mass spectrometry

Agilent s LC/MS Portfolio and Applications Examples

Protein Bioinformatics ( )

W.M. Keck Foundation Biotechnology Resource Laboratories. Erol Gulcicek Christopher Colangelo Terence Wu

One Gene, Many Proteins. Applications of Mass Spectrometry to Proteomics. Why Proteomics? Raghothama Chaerkady, Ph.D.

Supporting information

The Detection of Allergens in Food Products with LC-MS

Jose Castro-Perez, Henry Shion, Kate Yu, John Shockcor, Emma Marsden-Edwards, Jeff Goshawk Waters Corporation, Milford, MA, U.S. and Manchester, UK

Proteome analysis Cellular proteomics Plasma proteomics

Biological Mass Spectrometry. April 30, 2014

MSSimulator. Simulation of Mass Spectrometry Data. Chris Bielow, Stephan Aiche, Sandro Andreotti, Knut Reinert FU Berlin, Germany

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

Application of LC/Electrospray Ion Trap Mass Spectrometry for Identification and Quantification of Pesticides in Complex Matrices

Transcription:

MS/MS to Targeted Proteomics (MRM) How it worked on the Human Lens Proteome Jayson Falkner PhD jay@singleorganism.com

Genes Show Limited Value in Predicting Diseases With only a few exceptions, what the genomics companies are doing right now is recreational genomics, Dr. Goldstein said in an interview. The information has little or in many cases no clinical relevance. The undiscovered share of genetic risk for common diseases, he said, probably lies not with rare variants, as suggested by Dr. Goldstein, but in unexpected biological mechanisms. Nicholas Wade, New York Times, April 15 th 2009

Genomics has already arrived Commercial Products Affymetrix: Genome Wide Human SNP Array 6.0 (906,600 SNPs) Illumina: human1m-duo bead chip (1.1 million evenly distributed loci) Commercial Services decodeme: http://www.decodeme.com/ Complete Scan, Cardio Scan, Cancer Scan 23andMe: https://www.23andme.com/ Time Magazine s 2008 Invention of the Year, now $399.

Proteomics is arriving Tandem Mass Spectrometry (MS/MS) Discovery of proteins and post-translational modifications in a sample. Targeted Proteomics (MRM aka SRM) Rapid and sensitive monitoring of proteins and post-translational modifications in a sample.

Proteomics Timeline Peptide Ionization: ESI and MALDI Fenn et al. (1989). "Electrospray ionization for mass spectrometry of large biomolecules". Science (journal) 246: 6471. Tanaka et al (1988). "Protein and Polymer Analyses up to m/z 100 000 by Laser Ionization Time-of flight Mass Spectrometry". Rapid Commun Mass Spectrom 2 (20): 151 153. MS/MS: LCQ and Sequest Eng et al. (1994). "An Approach to Correlate Tandem Mass Spectral Data of Peptides with Amino Acid Sequences in a Protein Database". J Am Soc Mass Spectrom 5: 976 989. news.google.com proteomics On-line Separation: MudPIT Washburn et al. (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology Nat Biotech Vol 19 MRM: MIDAS and QTRAP Unwin et al (2005) Multiple Reaction Monitoring to Identify Sites of Protein Phosphorylation with High Sensitivity MCP 4.8

MS/MS Peptide Identification Eng et al. (1994). J Am Soc Mass Spectrom 5: 976 989.

MudPIT: More MS/MS Peptide Identifications Washburn et al. Nat. Biotech (19) 2001

Challenges in MS/MS Speed and Sensitivity Keshishian et al, MCP 2007 Measuring Changes ICAT: Gygi et al, Nat. Biotech 1999 SILAC: Ong et al, MCP 2002 ITRAQ: Ross et al, MCP 2004 AQUA: Kirkpatrick, Methods 2005 Post-translational Modifications Bonanza: Falkner et al, JPR 2008

The Promise of MRM Works only on known targets More sensitive and faster than MS/MS Better lower level of detection Can monitor low m/z ions Minimal fractionation required (10 min gradients!?) 5-10% CV and absolute quant Heavy labeled peptides required

MRM: Triple Quadrupoles Hager Rapid Comm. Mass Spec. 2002; 16: 512-526 Better by design vs 3D trap Holds more ions, 2x injection, 8x ion ejection No low mass loss (aka 1/3 rd m/z issue) EPI mode filters only the ion of interest

MRM: Known Targets Keshishian et al MCP 6.12 2007

MRM: Known Targets Keshishian et al MCP 6.12 2007

MRM: Absolute Quant Keshishian et al MCP 6.12 2007 Plasma = most complex background 2.5ng/ml at least for quant CVs less than 15% and ~5% on average 1000-fold LOQ increase from IgY-12

http://lens.singleorganism.com

Revising Analysis Strategies Initial Plan MS/MS MudPIT of data MS/MS quantification (O18 labeling) Spectral count to compare proteins and mods Revised Plan Reanalyze MS/MS survey data MRM relative quant w/exogenous standard Compare proteins and mods

MS/MS Data to MRM 28 samples of ~40 fractions = 1,000+ LC-MS/ MS runs 330,000 spectra for cluster/p-mod analysis ~4,000 unique peak lists ~1,300 identified unique peak lists 3x transition per peptide; i.e. ~12,000 trans Picked 400 targets to scout (1,200 trans) 4 MRM methods w/100 targets each (300 trans per run) Final MRM method with 300 targets (900 trans)

MS/MS Data to MRM Cluster 330,000 MS/MS spectra w/identifications QTOF + Sequest Analysis 2,700 Unknown 1,300 Identified 4,000 Unique MS/MS spectra Mr. M Hand picked 400 targets (1,200 transitions) List A List B List C List D QTRAP 4000 4 lists of 300 transitions each (unscheduled) QTRAP transitions per block limit Mr. M Scheduled MRM ~300 targets (900 trans) ~45 min per sample per LC-MRM

MS/MS Similarity Grouping Falkner et al, J. Proteome Res., 2008, 7 (11)

Example cluster

Example cluster

Identified Peak Lists Before and After Cluster Analysis Sequest + Decoy Sequest + Decoy + Cluster

MRM AUC Sensitivity

MRM Quant Variance 10-30% CV prior to correction 5-15% CV w/exogenous protein standard

MRM of Tricky P-mods +1 Da; too small to target Software can target using RP shift

Conclusion MS/MS works well for discovery MudPIT takes a long time (weeks) Build a library for MRM use MRM works well for monitoring Monitor ~300 targets in <1 hour Great sensitivity Minimal sample variance Minimal sample handling